1. Home
  2. BLMN vs ANIP Comparison

BLMN vs ANIP Comparison

Compare BLMN & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLMN
  • ANIP
  • Stock Information
  • Founded
  • BLMN 1988
  • ANIP 2001
  • Country
  • BLMN United States
  • ANIP United States
  • Employees
  • BLMN N/A
  • ANIP N/A
  • Industry
  • BLMN Restaurants
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLMN Consumer Discretionary
  • ANIP Health Care
  • Exchange
  • BLMN Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • BLMN 1.4B
  • ANIP 1.2B
  • IPO Year
  • BLMN 2012
  • ANIP N/A
  • Fundamental
  • Price
  • BLMN $12.11
  • ANIP $58.35
  • Analyst Decision
  • BLMN Hold
  • ANIP Buy
  • Analyst Count
  • BLMN 11
  • ANIP 7
  • Target Price
  • BLMN $16.90
  • ANIP $77.33
  • AVG Volume (30 Days)
  • BLMN 1.8M
  • ANIP 249.7K
  • Earning Date
  • BLMN 02-21-2025
  • ANIP 02-27-2025
  • Dividend Yield
  • BLMN 7.95%
  • ANIP N/A
  • EPS Growth
  • BLMN N/A
  • ANIP N/A
  • EPS
  • BLMN N/A
  • ANIP N/A
  • Revenue
  • BLMN $4,547,161,000.00
  • ANIP $555,456,000.00
  • Revenue This Year
  • BLMN N/A
  • ANIP $25.48
  • Revenue Next Year
  • BLMN N/A
  • ANIP $20.24
  • P/E Ratio
  • BLMN N/A
  • ANIP N/A
  • Revenue Growth
  • BLMN N/A
  • ANIP 23.60
  • 52 Week Low
  • BLMN $11.03
  • ANIP $52.50
  • 52 Week High
  • BLMN $30.13
  • ANIP $70.81
  • Technical
  • Relative Strength Index (RSI)
  • BLMN 49.52
  • ANIP 61.44
  • Support Level
  • BLMN $11.15
  • ANIP $52.74
  • Resistance Level
  • BLMN $11.99
  • ANIP $55.21
  • Average True Range (ATR)
  • BLMN 0.55
  • ANIP 1.52
  • MACD
  • BLMN 0.06
  • ANIP 0.55
  • Stochastic Oscillator
  • BLMN 60.00
  • ANIP 86.04

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: